POLYNUCLEAR TETRAZOLE-CONTAINING AMINO ACID ANALOGS
1529
Scheme 2.
N
N
N
SiCl4, NaN3
Me
NH
N
N
N
N
N
N
N
N
ClCH2CONH2, Et3N
Me
Me
III
H
CONH2
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
(1) NaOH
(2) HCl
I
II
Me
COOH
N
N
N
N
N
N
N
N
IV
1
The H and 13C NMR spectra were recorded on
a Bruker DPX-300 spectrometer at 300 and 75 MHz,
respectively, using DMSO-d6 as solvent and reference.
The progress of reactions and the purity of products
were monitored by TLC on Kieselgel 60 F254 plates
(Merck) using CHCl3–MeOH (9:1 or 95:5) as eluent;
spots were visualized with UV light.
described in [7, 8]. The alkylation of ditetrazole I
afforded a mixture of isomers, N2-isomer II prevailing.
Pure compound II was isolated by recrystallization
from ethanol.
Low toxicity and high resistance to biochemical
decomposition are the main factors responsible for
successful application of tetrazole derivatives as iso-
steric analogs of carboxy group in molecular design of
medical agents [9]. Furthermore, pKa values of car-
boxylic acids and the corresponding NH-tetrazoles
differ only slightly [10]. In the present work we deter-
mined by potentiometric titration acidity constants of
some previously synthesized compounds V–VII [7, 8],
as well as of the new polynuclear tetrazole-containing
analogs of (D,L)-phenylalanine (compounds III and
IV) (see below). It is seen that the pKa values of the
examined NH-tetrazoles and the corresponding car-
boxylic acids are very similar, in keeping with the
known relation. On the other hand, the NH and COOH
acidities of compounds I and III–VII are relatively
high, presumably due to electron-acceptor effect of the
tetrazole rings.
(R,S)-5-[1-(5-Methyl-1-tetrazolyl)-2-phenyl-
ethyl]-2-tetrazolylacetamide (II). Chloroacetamide,
4.77 g (0.051 mol), was added with stirring to a mix-
ture of 10.9 g (0.043 mol) of compound I, 90 ml of
acetonitrile, and 5.16 g (0.051 mol) of triethylamine.
The mixture was heated for 6–7 h under reflux (TLC),
the solvent was removed under reduced pressure, and
the residue was treated with a 1:1 ethyl acetate–water
mixture. The organic phase was separated, the solvent
was removed under reduced pressure, and the residue
was recrystallized from a minimal amount of ethanol.
Yield 8.91 g (67%), light yellow crystals. An analytical
sample was obtained by repeated recrystallization from
1
ethanol, mp 133–135°C. H NMR spectrum, δ, ppm:
2.25 s (3H, CH3), 3.65–3.80 m (1H, CH2Ph), 3.92 d.d
(1H, CH2Ph, J = 5.1, 13.8 Hz), 5.48 s (2H, CH2CO),
6.59 d.d (1H, CH, J = 5.1, 10.9 Hz), 7.10–7.25 m
(5H, Harom), 7.24 br.s and 7.56 br.s (1H each, CONH2).
13C NMR spectrum, δC, ppm: 8.1 (CH3); 37.8 (CH2Ph);
54.4 (CH2CO); 54.8 (CH); 127.2, 128.4, 129.1, 135.4
(Carom); 152.5 (CCH3); 163.0 (CCH), 165.7 (CONH2).
Found, %: C 50.10; H 5.25; N 40.38. C13H15N9O. Cal-
culated, %: C 49.83; H 4.83; N 40.24.
EXPERIMENTAL
Potentiometric measurements were performed
using a pH-121 potentiometer equipped with an ESL-
43-07 glass electrode, an EVL-1M3 silver chloride
electrode, and a temperature-controlled cell (25°C).
The titration was carried out in 50% aqueous methanol
which was freed from carbon dioxide; a 0.1 N solution
of sodium hydroxide was used as titrant, and a 0.1 N
solution of sodium nitrate, as supporting electrolyte.
The pKa values were calculated as described in [11].
(R,S)-5-[1-(5-Methyl-1-tetrazolyl)-2-phenyl-
ethyl]-2-(5-tetrazolylmethyl)tetrazole (III). A reactor
equipped with a reflux condenser (capped with a dry-
ing tube) and a magnetic stirrer was charged with 5.0 g
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 40 No. 10 2004